A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

Clinical trial NCT03482024 · COMPLETED

Trial details

NCT number: NCT03482024
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Insufficiency End Stage Renal Disease

Start date: 2018-03-30
Primary completion: 2019-08-19
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.